Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 121 - 128 of 11616 results
SEC Approves Nasdaq Rule Change on Reverse Stock Splits and Minimum Bid Price Compliance Timing
October 17, 2024| Alert| Viewpoint
String Of Numbers Or Identifier: The Ninth Circuit Weighs In On BIPA’s Application To Non-Users
October 17, 2024| Blog| Viewpoint
How Project 2025 Could Upend Federal ESG Policies
October 17, 2024| News
Led by DOJ, Federal Agencies Convene to Coordinate Safeguarding Civil Rights from AI-Related Harms — AI: The Washington Report
October 16, 2024| Article| Viewpoint
Off-Cycle Nursing Facility Revalidations Are Starting: Is Your SNF Ready for the Required Disclosures?
October 15, 2024| Blog| Viewpoint
The Murky Waters of Wash Trading Digital Assets – DOJ Charges 18 Individuals and Entities
October 15, 2024| Blog| Viewpoint
G7 Competition Authorities, Including DOJ and FTC, Release Joint Statement on AI Competition — AI: The Washington Report
October 11, 2024| Article| Viewpoint
Health Law Diagnosed – Women Leaders in Health Care: Investing in Women’s Health
October 11, 2024| Podcast| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.
Events
Podcasts
The ‘Third Inning’ of the Energy Transition
December 6, 2024| Podcast|
Mintz on Air - Predictions and Practical Policies
November 25, 2024| Podcast|